Why the study?
BKCa channels play a crucial role in maintaining the homeostasis of the micturition cycle and airway-related functions, motivating the optimization of novel BKCa channel activators.
Novel diphenyl ether derivatives act as potent BKCa channel activators with demonstrated in vivo efficacy for urinary incontinence and cough suppression, supported by cryo-EM structural insights.
Hypothesis-generating for BKCa activators in incontinence and cough; requires clinical trials before any therapeutic consideration.
The BK Ca channel, a large-conductance calcium-activated potassium channel, plays a crucial role in maintaining the homeostasis of the micturition cycle and airway-related functions. In this study, we optimized a novel BK Ca channel activator, 4d, with a diphenyl ether structure identified from library screening. This led to the discovery of potent activators, 10b (EC 50 = 0.12 μM, cell-based assay) and 51b, an orally bioavailable derivative. Compound 10b demonstrated potent in vivo efficacy in a spontaneous hypertensive rat (SHR) of urinary incontinence model, while compound 51b showed dose-dependent cough suppression efficacy with an ED 50 of 11.8 mg/kg in a citric acid-induced cough model. Furthermore, we reported the cryo-electron microscopy (cryo-EM) structures of the BK Ca channel in complex with 10b and 51b at resolutions of 2.8 and 3.4 Å. Based on structural analyses, we determined the binding sites and key interaction residues of 51b, which were validated via mutation studies.
No takes yet. Share an insight, caveat, or question.
Park et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: